Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (811-820 of 831) with videos related to

Pageof 84
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Acta Neuropathologica|March 19, 2021
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutationsC Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, et al.
EMBO Molecular Medicine|February 17, 2022
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasisLucía Zhu, Diana Retana, Pedro García-Gómez, et al.
Neuro-Oncology|August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future DirectionsPatrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Neuro-Oncology|May 2, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patientsJustin Z Wang, Alexander P Landry, David R Raleigh, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Pageof 84

Showing results (811-820 of 831) with videos related to

Sort By:
Pageof 84
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Cancer Research|December 20, 2023
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment RegimenTathiane M Malta, Thais S Sabedot, Natalia S Morosini, et al.
Nature Medicine|May 27, 2025
Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Acta Neuropathologica|March 19, 2021
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutationsC Mircea S Tesileanu, Wies R Vallentgoed, Marc Sanson, et al.
EMBO Molecular Medicine|February 17, 2022
A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasisLucía Zhu, Diana Retana, Pedro García-Gómez, et al.
Neuro-Oncology|August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future DirectionsPatrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Neuro-Oncology|May 2, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patientsJustin Z Wang, Alexander P Landry, David R Raleigh, et al.
Acta Neuropathologica|March 23, 2018
Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterationsAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
The Lancet. Oncology|November 27, 2025
A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect groupPhilipp Karschnia, Jacob S Young, Maarten M J Wijnenga, et al.
Pageof 84